share_log

Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co.

Benzinga Real-time News ·  Mar 15, 2021 09:53
Obalon Therapeutics Amended 13D Filing From Domain Partners VII Shows 9.8% Stake In Co.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment